By Daniella Parra March Biosciences was granted an orphan drug designation from the FDA to MB-105, its CD5-targeted CAR-T ...

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

Cancer still eludes treatment, and tumors frequently evolve resistance mechanisms to get around medications. By making cancer ...

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma: Houston Thursday, January 30, 2025, 17:00 Hrs [IST] ...

The United States has approved an emergency humanitarian waiver allowing continued access to HIV treatment funded by the U.S.

Bristol-Myers Squibb (NYSE:BMY), a global biopharmaceutical company with a market capitalization of nearly $120 billion, finds itself at a critical juncture as it navigates a complex landscape of ...

Whether you want to relieve pain, reduce stress, or promote holistic well-being, these are some of the best alternative ...

Usually described as a splitting or multiple personality disorder, the concept of schizophrenia is not entirely but rather a ...

One woman's journey from OCD to empowerment through comedy, offering hope and humor to others facing mental health challenges ...

Having lived with disabling chronic pain for 32 years, one reader discovered a lesser known treatment that has transformed ...

Taiho Pharmaceutical Co., Ltd., Taiho Oncology, Inc., and Cullinan Therapeutics, Inc. have announced the successful outcome ...